Axitinib (Inlyta,Asidx)

Axitinib is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma (RCC) following failure of prior systemic therapy.

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Axitinib Medication Guide

Purchase Channels for Axitinib

Axitinib is a targeted therapeutic agent for renal cell carcinoma, which has been increasingly widely used in clinical practice in recent years. Devel···【More】
Update: 18 Mar,2026Source: BigbearViews: 97
When to Immediately Discontinue the Use of Axitinib

Discontinue medication if any of the following situations occur:When to Discontinue TreatmentReversible Posterior Leukoencephalopathy Syndrome (RPLS)M···【More】
Update: 25 Feb,2026Source: BigbearViews: 95
How to Take Axitinib Correctly

Axitinib is an oral targeted anti-tumor medication classified as a tyrosine kinase inhibitor (TKI). It functions by inhibiting Vascular Endothelial Gr···【More】
Update: 25 Feb,2026Source: BigbearViews: 97